c-Met/HGFR
Gli inibitori di c-Met/HGFR mirano al Recettore del Fattore di Crescita degli Epatociti (c-Met), una tirosina chinasi coinvolta in processi cellulari come crescita, motilità e morfogenesi. La segnalazione di c-Met è implicata nella progressione del cancro, nella metastasi e nella resistenza alle terapie. L'inibizione di c-Met può interrompere la crescita e la diffusione del tumore, rendendo questi inibitori preziosi nella ricerca sul cancro. Presso CymitQuimica, offriamo inibitori di c-Met/HGFR per supportare la tua ricerca in oncologia, metastasi e terapie oncologiche mirate.
Trovati 148 prodotti per "c-Met/HGFR".
Filtra per
Percentuale di purezza
0
100
|
0
|
50
|
90
|
95
|
100
- Prezzo più basso
- Prezzo più alto
- Purezza più bassa
- Purezza più alta
- Consegna più veloce
Pamufetinib
CAS:Pamufetinib (TAS-115) is a potent inhibitor of VEGFR and hepatocyte growth factor receptor (c-Met/HGFR)-targeted kinase.Formula:C27H23FN4O4SPurezza:99.39%Colore e forma:White SolidPeso molecolare:518.56Ref: TM-T13108
1mg52,00€5mg101,00€1mL*10mM (DMSO)111,00€10mg149,00€25mg244,00€50mg359,00€100mg510,00€200mg695,00€Emibetuzumab
CAS:Emibetuzumab: potent humanized MET antibody, antitumor, inhibits HGF/MET pathways, for advanced prostate cancer research.Purezza:95% - 98.2% (SDS-PAGE); 98.82% (SEC-HPLC)Colore e forma:Transparent LiquidPeso molecolare:143.74 kDa (Predicted)SU 5616
CAS:SU 5616 (WAY-608241) regulates abnormal cell proliferation and modulates tyrosine kinase signaling.Formula:C13H8ClNOSPurezza:98.84%Colore e forma:SolidPeso molecolare:261.73Ref: TM-T72021
1mg34,00€1mL*10mM (DMSO)67,00€5mg71,00€10mg100,00€25mg166,00€50mg245,00€100mg354,00€200mg495,00€Onartuzumab
CAS:Onartuzumab (MetMAb) is a humanized monoclonal antibody targeting c-MET, with antitumor effects by blocking HGF and signal transduction.Purezza:97.3%Colore e forma:Transparent LiquidPeso molecolare:146.99 kDa (Predicted)c-Met inhibitor 1
CAS:c-Met inhibitor 1 is a c-Met receptor signaling pathway inhibitor, used for the treatment of cancer including glioblastoma, gastric, and pancreatic cancer.Formula:C17H14N8SPurezza:98.77%Colore e forma:SolidPeso molecolare:362.41CSF1R-IN-2
CAS:CSF1R-IN-2 is an oral-active SRC, MET and c-FMS inhibitor (IC50s: 0.12 nM, 0.14 nM and 0.76 nM for SRC, MET and c-FMS respectively).Formula:C20H20FN7O2Purezza:99.29%Colore e forma:SolidPeso molecolare:409.42JNJ-38877618
CAS:JNJ-38877618 (OMO-1) is an effective and highly selective inhibitor of Met kinase (IC50s: 2 and 3 nM for wild type and mutant Met, respectively).Formula:C20H12F2N6Purezza:98.84% - 99.74%Colore e forma:Yellow SolidPeso molecolare:374.35Ref: TM-T15617
1mg59,00€5mg130,00€1mL*10mM (DMSO)144,00€10mg200,00€25mg401,00€50mg557,00€100mg737,00€Bozitinib
CAS:Bozitinib (PLB-1001) (PLB-1001) is a highly selective inhibitor of the c-MET kinase with blood-brain barrier permeability.Formula:C20H15F3N8Purezza:99.16%Colore e forma:SolidPeso molecolare:424.38Ref: TM-T10585
1mg92,00€5mg205,00€1mL*10mM (DMSO)227,00€10mg334,00€25mg595,00€50mg858,00€100mg1.198,00€200mg1.611,00€Rilotumumab
CAS:Rilotumumab (AMG 102) is an HGF-targeting antibody, inhibits HGF/MET signaling, and is used for CRPC and gastric cancer research.Purezza:SDS-PAGE:95% SEC-HPLC:97.51%Colore e forma:Transparent LiquidPeso molecolare:145.2 kDa (Predicted)PROTAC c-Met degrader-2
CAS:PROTACc-Met degrader-2 (PROTAC2) is a c-Met degrader developed using PROTAC technology, with a DC50 value of 50 nM.Formula:C51H50F2N6O13Colore e forma:SolidPeso molecolare:992.97c-Met ligand-Linker Conjugate 1
c-Met ligand-Linker Conjugate 1 is a Target Protein Ligand-Linker Conjugate that consists of a c-Met ligand and a PROTAC linker, capable of recruiting E3 ligase. This compound is used in the synthesis of PROTACc-Met degrader-5.Colore e forma:Odour SolidFosgonimeton acetate
Fosgonimeton acetate is an agonist of hepatocyte growth factor (HGF).Formula:C29H49N4O10PPurezza:98.01%Colore e forma:SolidPeso molecolare:644.69c-Met-IN-23
c-Met-IN-23 (Compound 12g) functions as a c-Met inhibitor with an IC50 of 0.052 μM against c-Met. It also inhibits the MDR1 and MRP1/2 pumps in cancerous HepG2 and BxPC3 cells. As such, c-Met-IN-23 serves as an anticancer agent.Formula:C16H13N7OPeso molecolare:319.11816Zurletrectinib
CAS:Zurletrectinib is a tyrosine kinase inhibitor with potential as an antineoplastic agent.Formula:C19H19F2N7O2Colore e forma:SolidPeso molecolare:415.4Caveolin-1 (82-101) amide (human, mouse, rat)
CAS:Caveolin-1 (82-101) amide (human, mouse, rat), also known as Caveolin-1 scaffolding domain peptide, mitigates aging-related detrimental alterations in variousFormula:C124H170N28O29Purezza:98%Colore e forma:SolidPeso molecolare:2516.85PROTAC c-Met Degrader-4
CAS:PROTACc-Met Degrader-4 (compound D15) is a potent and orally active PROTACc-MET degrader. It demonstrates exceptional intracellular degradation activity with a DC50 of less than 0.5 nM. This compound can induce cell cycle arrest and apoptosis (apoptosis), inhibit cell invasion and migration, thereby suppressing cell proliferation. It also inhibits the growth of Hs746T xenograft tumors in nude mice. PROTACc-Met Degrader-4 is applicable in cancer research, including studies on non-small cell lung cancer and gastric cancer.Formula:C47H44N10O7Peso molecolare:860.93PROTAC c-Met degrader-3
PROTACc-Met degrader-3 (Compound 22b) is a c-Met PROTAC degrader. It facilitates the ubiquitination and degradation of c-Met, with a DC50 of 0.59 nM in EBC-1 cells. PROTACc-Met degrader-3 is applicable in lung cancer research.Formula:C51H54N10O7Colore e forma:SolidPeso molecolare:919.037LMTK3-IN-1
CAS:Lmtk3-in-1 is a potent ATP-competitive lemur tyrosine kinase 3 (LMTK3) (Kd=2.5 μM) inhibitor that degrades LMTK3 through the ubiquitin proteasome pathway.Formula:C18H11F3N4OPurezza:99.58%Colore e forma:Yellow SolidPeso molecolare:356.3Norleual
CAS:Angiotensin IV analog, potent HGF/c-MET inhibitor (IC50=3 pM), halts MDCK cell growth and invasion, AT4 antagonist, impairs LTP, antiangiogenic.Formula:C41H58N8O7Purezza:98%Colore e forma:SolidPeso molecolare:774.95PF-04217903 phenolsulfonate
CAS:PF-04217903 phenolsulfonate is a potent ATP-competitive inhibitor of c-Met kinase (Ki of 4.8 nM for human c-Met).Formula:C25H22N8O5SPurezza:98%Colore e forma:SolidPeso molecolare:546.56
